Segment Information (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following is a summary of our segment and consolidated net loss, including significant segment expenses:

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
	(in thousands)
Collaboration revenue	$	—	$	1,143	$	—	$	1,885
Less:
Clinical development	5,710		5,684		10,039		8,412
General and administrative support	3,486		3,621		7,309		7,360
Research and discovery	3,537		3,270		6,856		7,545
Manufacturing	2,610		4,472		6,698		8,865
Other segment expenses(a)	2,199		3,056		4,631		5,825
Interest income	850		1,793		1,847		3,766
Interest expense	(1,301)		(1,142)		(2,564)		(2,145)
Loss on extinguishment of debt	—		(553)		—		(553)
Other income, net	11		1,613		179		1,612
Segment and consolidated net loss	$	(17,982)	$	(17,249)	$	(36,071)	$	(33,442)

(a) Other segment expenses includes non-cash expenses for stock-based compensation and depreciation expenses.